Autologous hematopoietic stem cell transplant in a patient with leprosy: Is it safe?
Matias Chiarastelli SalomãoMarjorie Vieira BatistaMaria Cristina de MacedoMirian Nacagami SottoAmaro Nunes DuarteVanderson Geraldo RochaHermes Ryoiti HigashinoSilvia Figueiredo CostaPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2018)
A patient with non-Hodgkin lymphoma, preparing for an autologous hematopoietic stem cell transplant (HSCT), developed leprosy. The patient was successfully treated with rifampicin, ofloxacin, and doxycycline, and the HSCT was performed without complications, being the first report, to our knowledge, of leprosy in an autologous HSCT patient.